Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Ergotism”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1991

[Ergot in feed--the clarification of possible ergot-related infirmity cases].

Practicing veterinarians should realize that the symptoms of ergot intoxication may differ markedly. Gangrenous alterations (ears, feet, tail) as well as convulsive signs (excitability) are described as typical symptoms of ergotism. It is noteworthy that inadequate development of the udder and lactation failure may also be related to ergot contaminated diets. Ergot contamination of diets is caused by grain infection with Claviceps purpurea and sometimes by infection of grass and weed (in grain). The frequency of ergot contamination is high in rye, triticale and wheat and varies in relation to region, climatic conditions and kind of wheat. For diagnosis of ergot contamination a thorough visual inspection of the used diet is to be recommended. Due to the variation of ergots (infected grain, infected weed) it is difficult to determine the contamination in prepared feed mixtures. The anamnestic procedure, method of visual feed inspection as well as a chromatographic method for detection of ergot alkaloids in feed samples are described to facilitate the detection of possible ergot related cases.

Animal Feed↗
PubMed1980

Characterization of ergot and non-ergot serotonin antagonists by prolactin and growth hormone profiles during wakefulness and sleep.

In order to further clarify the involvement of serotonin in the control of secretion of pituitary lactogens, diurnal and sleep prolactin (PRL) and growth hormone (GH) profiles were investigated in healthy subjects treated with ergot and non-ergot serotonin antagonists. A group of 10 subjects received a single oral dose of 2 mg each of pizotifen, methysergide, and the dopaminergic drug bromocriptine as reference substance, in comparison with placebo. Blood was collected at hourly intervals for 6 h. Another group of 10 individuals received either a placebo, 2.5 mg bromocriptine (n = 6) twice daily for 4 days or pizotifen (n = 10) 0.5 mg 3 times daily for 12 days before undergoing EEG recording and blood sampling during night sleep. The diurnal plasma profiles of PRL and GH were not modified by pizotifen, a non-ergot drug. Methysergide and bromocriptine, two ergot derivatives, significantly (P < 0.01 and P < 0.001 respectively) suppressed the basal secretion of PRL throughout the trial and increased plasma GH significantly (P < 0.01). The sleep profile of PRL was not modified by pizotifen but there was a moderate reduction in GH reaching the level of significance (P < 0.02) between hours 1 and 2 of sleep. Bromocriptine suppressed completely PRL secretion throughout the entire sleep period and significantly (P < 0.05) prolonged the secretory profile of GH. The results indicate the presence in the ergot molecule of a dopaminergic moiety responsible for PRL inhibition and GH stimulation. This effect is independent of the serotonin active component of the drug.

Adult↗
PubMed2005

The influence of ergot-contaminated feed on growth and slaughtering performance, nutrient digestibility and carry over of ergot alkaloids in growing-finishing pigs.

Diets containing 0, 1 and 10 g ergot (Claviceps purpurea) per kg, corresponding to mean total alkaloid contents of 0.05, 0.60 and 4.66 mg/kg (sums of ergometrine, ergotamine, ergocornine, alpha-ergocryptine, ergocristine, ergosine and their -inine isomers analysed by a HPLC-method), were each fed ad libitum to 12 pigs in the BW range of 30-115 kg to study the effect of ergot-contaminated feed on growth and slaughtering performance and the carry over of ergot alkaloids. Additionally, balance trials were conducted to investigate the digestibility of nutrients. Tendencies towards reduced feed intake and BWG were observed at a feeding level of 4.66 mg total alkaloids per kg diet. Typical symptoms of ergot poisoning were not observed. Heart and spleen weights showed significant linear increases. Differences in carcass quality due to dietary treatment were not detected. No genuine ergot alkaloids were found in physiological samples. The balance trials demonstrated a significantly decreased protein digestibility for the most highly supplemented diet.

Animal Feed↗
PubMed1995

History of ergot alkaloids from ergotism to ergometrine.

Epidemics of ergotism occurred frequently in the Middle Ages. They were a source of inspiration for artists and were popularly known as 'St. Anthony's Fire', resulting in gangrene, neurological diseases and death. It was caused by eating rye bread contaminated with the fungus claviceps purpurea. In 1582 it was described that a delivery could be hastened by administering a few spurs of the secale cornutum. The dosage was, however, very inaccurate resulting in frequent uterine ruptures. The nickname of the preparation of 'pulvis ad partum' was changed to 'pulvis ad mortem'. Therefore, after 1828 the ergot alkaloids were no longer used during delivery but only as a measure to prevent postpartum haemorrhage. From 1875 onwards many derivatives of ergot alkaloids were found. Dudley and Moir isolated ergometrine in 1932. It proved to have a very specific uterotonic action. However, because of severe and unpredictable side effects and the instability of the drug, ergometrine is not the drug of choice for either the prevention or the treatment of postpartum haemorrhage.

Ergonovine↗